158 related articles for article (PubMed ID: 20215524)
1. Loss of DNA polymerase zeta enhances spontaneous tumorigenesis.
Wittschieben JP; Patil V; Glushets V; Robinson LJ; Kusewitt DF; Wood RD
Cancer Res; 2010 Apr; 70(7):2770-8. PubMed ID: 20215524
[TBL] [Abstract][Full Text] [Related]
2. Dual role for mammalian DNA polymerase ζ in maintaining genome stability and proliferative responses.
Lange SS; Bedford E; Reh S; Wittschieben JP; Carbajal S; Kusewitt DF; DiGiovanni J; Wood RD
Proc Natl Acad Sci U S A; 2013 Feb; 110(8):E687-96. PubMed ID: 23386725
[TBL] [Abstract][Full Text] [Related]
3. Loss of DNA polymerase zeta causes chromosomal instability in mammalian cells.
Wittschieben JP; Reshmi SC; Gollin SM; Wood RD
Cancer Res; 2006 Jan; 66(1):134-42. PubMed ID: 16397225
[TBL] [Abstract][Full Text] [Related]
4. DNA polymerase zeta contributes to heterochromatin replication to prevent genome instability.
Ben Yamin B; Ahmed-Seghir S; Tomida J; Despras E; Pouvelle C; Yurchenko A; Goulas J; Corre R; Delacour Q; Droin N; Dessen P; Goidin D; Lange SS; Bhetawal S; Mitjavila-Garcia MT; Baldacci G; Nikolaev S; Cadoret JC; Wood RD; Kannouche PL
EMBO J; 2021 Nov; 40(21):e104543. PubMed ID: 34533226
[TBL] [Abstract][Full Text] [Related]
5. A single aspartate mutation in the conserved catalytic site of Rev3L generates a hypomorphic phenotype in vivo and in vitro.
Fritzen R; Delbos F; De Smet A; Palancade B; Canman CE; Aoufouchi S; Weill JC; Reynaud CA; Storck S
DNA Repair (Amst); 2016 Oct; 46():37-46. PubMed ID: 27481099
[TBL] [Abstract][Full Text] [Related]
6. The role of DNA polymerase ζ in benzo[a]pyrene-induced mutagenesis in the mouse lung.
Ishii Y; Takasu S; Grúz P; Masumura K; Ogawa K; Nohmi T; Umemura T
Mutagenesis; 2021 May; 36(2):155-164. PubMed ID: 33544859
[TBL] [Abstract][Full Text] [Related]
7. The Polymerase Activity of Mammalian DNA Pol ζ Is Specifically Required for Cell and Embryonic Viability.
Lange SS; Tomida J; Boulware KS; Bhetawal S; Wood RD
PLoS Genet; 2016 Jan; 12(1):e1005759. PubMed ID: 26727495
[TBL] [Abstract][Full Text] [Related]
8. The translesion polymerase Rev3L in the tolerance of alkylating anticancer drugs.
Roos WP; Tsaalbi-Shtylik A; Tsaryk R; Güvercin F; de Wind N; Kaina B
Mol Pharmacol; 2009 Oct; 76(4):927-34. PubMed ID: 19641035
[TBL] [Abstract][Full Text] [Related]
9. REV7 is essential for DNA damage tolerance via two REV3L binding sites in mammalian DNA polymerase ζ.
Tomida J; Takata K; Lange SS; Schibler AC; Yousefzadeh MJ; Bhetawal S; Dent SY; Wood RD
Nucleic Acids Res; 2015 Jan; 43(2):1000-11. PubMed ID: 25567983
[TBL] [Abstract][Full Text] [Related]
10. REV3L, a promising target in regulating the chemosensitivity of cervical cancer cells.
Yang L; Shi T; Liu F; Ren C; Wang Z; Li Y; Tu X; Yang G; Cheng X
PLoS One; 2015; 10(3):e0120334. PubMed ID: 25781640
[TBL] [Abstract][Full Text] [Related]
11. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability.
McCormack SJ; Weaver Z; Deming S; Natarajan G; Torri J; Johnson MD; Liyanage M; Ried T; Dickson RB
Oncogene; 1998 May; 16(21):2755-66. PubMed ID: 9652742
[TBL] [Abstract][Full Text] [Related]
12. Cooperating oncogenic events in murine mammary tumorigenesis: assessment of ErbB2, mutant p53, and mouse mammary tumor virus.
Zelazny E; Li B; Anagnostopoulos AM; Coleman A; Perkins AS
Exp Mol Pathol; 2001 Jun; 70(3):183-93. PubMed ID: 11417997
[TBL] [Abstract][Full Text] [Related]
13. Disruption of the Rev3l-encoded catalytic subunit of polymerase zeta in mice results in early embryonic lethality.
Esposito G; Godindagger I; Klein U; Yaspo ML; Cumano A; Rajewsky K
Curr Biol; 2000 Oct; 10(19):1221-4. PubMed ID: 11050393
[TBL] [Abstract][Full Text] [Related]
14. REV3L modulates cisplatin sensitivity of non-small cell lung cancer H1299 cells.
Wang W; Sheng W; Yu C; Cao J; Zhou J; Wu J; Zhang H; Zhang S
Oncol Rep; 2015 Sep; 34(3):1460-8. PubMed ID: 26165320
[TBL] [Abstract][Full Text] [Related]
15. Developmental delay with hypotrophy associated with homozygous functionally relevant REV3L variant.
Halas A; Fijak-Moskal J; Kuberska R; Murcia Pienkowski V; Kaniak-Golik A; Pollak A; Poznanski J; Rydzanicz M; Bik-Multanowski M; Sledziewska-Gojska E; Płoski R
J Mol Med (Berl); 2021 Mar; 99(3):415-423. PubMed ID: 33474647
[TBL] [Abstract][Full Text] [Related]
16. Impact of ionizing radiation and genetic background on mammary tumorigenesis in p53-deficient mice.
Backlund MG; Trasti SL; Backlund DC; Cressman VL; Godfrey V; Koller BH
Cancer Res; 2001 Sep; 61(17):6577-82. PubMed ID: 11522657
[TBL] [Abstract][Full Text] [Related]
17. The MMTV/c-myc transgene and p53 null alleles collaborate to induce T-cell lymphomas, but not mammary carcinomas in transgenic mice.
Elson A; Deng C; Campos-Torres J; Donehower LA; Leder P
Oncogene; 1995 Jul; 11(1):181-90. PubMed ID: 7624126
[TBL] [Abstract][Full Text] [Related]
18. The associated contributions of p53 and the DNA mismatch repair protein Msh6 to spontaneous tumorigenesis.
Young LC; Keuling AM; Lai R; Nation PN; Tron VA; Andrew SE
Carcinogenesis; 2007 Oct; 28(10):2131-8. PubMed ID: 17615258
[TBL] [Abstract][Full Text] [Related]
19. Disruption of the developmentally regulated Rev3l gene causes embryonic lethality.
Wittschieben J; Shivji MK; Lalani E; Jacobs MA; Marini F; Gearhart PJ; Rosewell I; Stamp G; Wood RD
Curr Biol; 2000 Oct; 10(19):1217-20. PubMed ID: 11050392
[TBL] [Abstract][Full Text] [Related]
20. Loss of heterozygosity occurs via mitotic recombination in Trp53+/- mice and associates with mammary tumor susceptibility of the BALB/c strain.
Blackburn AC; McLary SC; Naeem R; Luszcz J; Stockton DW; Donehower LA; Mohammed M; Mailhes JB; Soferr T; Naber SP; Otis CN; Jerry DJ
Cancer Res; 2004 Aug; 64(15):5140-7. PubMed ID: 15289317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
